- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Repurposing metformin as a potential anticancer agent using in silico technique ; day:26 ; month:6 ; year:2024 ; pages:1-7
DARU ; (26.6.2024), 1-7
- Creator
-
Mahfauz, Mona
Yuruker, Ozel
Kalkan, Rasime
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40199-024-00523-0
- URN
-
urn:nbn:de:101:1-2409162120424.258994416732
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mahfauz, Mona
- Yuruker, Ozel
- Kalkan, Rasime
- SpringerLink (Online service)
Other Objects (12)
Metformin-induced anticancer activities: recent insights
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Drug repurposing against COVID-19: focus on anticancer agents
In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
In-Silico Design of an Anti-Cancer Vaccine
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer’s model mice
Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury
Modulation of autophagy, apoptosis and oxidative stress: a clue for repurposing metformin in photoaging
Repurposing Metformin for periodontal disease management as a form of oral-systemic preventive medicine
Metformin-induced anticancer activities: recent insights
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Drug repurposing against COVID-19: focus on anticancer agents
In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
In-Silico Design of an Anti-Cancer Vaccine
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer’s model mice
Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury
Modulation of autophagy, apoptosis and oxidative stress: a clue for repurposing metformin in photoaging
Repurposing Metformin for periodontal disease management as a form of oral-systemic preventive medicine
Metformin-induced anticancer activities: recent insights
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Drug repurposing against COVID-19: focus on anticancer agents
In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
In-Silico Design of an Anti-Cancer Vaccine
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer’s model mice
Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury
Modulation of autophagy, apoptosis and oxidative stress: a clue for repurposing metformin in photoaging